2016
DOI: 10.1021/acs.molpharmaceut.6b00687 View full text |Buy / Rent full text
|
|

Abstract: Active targeting and delivery to pathophysiological organs of interest is of paramount importance to increase specific accumulation of therapeutic drugs or imaging agents while avoiding systemic side effects. We recently developed a family of new peptide ligands of the human and rodent LDL receptor (LDLR), an attractive cell-surface receptor with high uptake activity and local enrichment in several normal or pathological tissues (Malcor et al., J. Med. Chem. 2012, 55 (5), 2227). Initial chemical optimization o… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
15
0

Publication Types

Select...

Relationship

0
0

Authors

Journals